Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Pelthos Therapeutics (PTHS) Return on Capital Employed (2024 - 2025)

Pelthos Therapeutics has reported Return on Capital Employed over the past 2 years, most recently at 0.32% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.32% for Q4 2025, down 357.0% from a year ago — trailing twelve months through Dec 2025 was 0.32% (down 357.0% YoY), and the annual figure for FY2025 was 0.81%, changed.
  • Return on Capital Employed for Q4 2025 was 0.32% at Pelthos Therapeutics, up from 0.57% in the prior quarter.
  • Over the last five years, Return on Capital Employed for PTHS hit a ceiling of 3.25% in Q4 2024 and a floor of 0.57% in Q3 2025.